Search research articles
Contact Us
Filters
Showing results (401-410 of 635) with videos related to
Page
of 64
Sort By:
Journal of the American Heart Association
|
October 30, 2018
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial
Gene R Quinn, Anne S Hellkamp, Graeme J Hankey, et al.
Journal of Thrombosis and Thrombolysis
|
July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Larry R Jackson, Sunghee Kim, Peter Shrader, et al.
American Heart Journal
|
September 29, 2014
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)
William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, et al.
Circulation
|
December 18, 2015
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
Jonathan P Piccini, Anne S Hellkamp, Jeffrey B Washam, et al.
European Heart Journal
|
September 25, 2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
J Antonio Gutierrez, Robert A Harrington, James C Blankenship, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Simke W Waijer, Taha Sen, Clare Arnott, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION program
J Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Page
of 64
Search research articles
Search
Showing results (401-410 of 635) with videos related to
Sort By:
Page
of 64
Journal of the American Heart Association
|
October 30, 2018
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial
Gene R Quinn, Anne S Hellkamp, Graeme J Hankey, et al.
Journal of Thrombosis and Thrombolysis
|
July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Larry R Jackson, Sunghee Kim, Peter Shrader, et al.
American Heart Journal
|
September 29, 2014
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)
William Schuyler Jones, Pierluigi Tricoci, Zhen Huang, et al.
Circulation
|
December 18, 2015
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
Jonathan P Piccini, Anne S Hellkamp, Jeffrey B Washam, et al.
European Heart Journal
|
September 25, 2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
J Antonio Gutierrez, Robert A Harrington, James C Blankenship, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Simke W Waijer, Taha Sen, Clare Arnott, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION program
J Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Page
of 64